Results 151 to 160 of about 9,549,304 (358)

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

open access: yesMolecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li   +10 more
wiley   +1 more source

Delta-8-THC acetate-a prodrug of delta-8-THC?: A case report

open access: yesForensic Science International: Reports
This case report describes the concurrent analysis of a seized plant material and a urine sample. The seized plant material was found to contain delta-8-THC acetate, a prodrug of delta-8-THC, as a major component.
Jonathan Wong   +5 more
doaj   +1 more source

Drugs, Alcohol, and Suicide Represent Growing Share of U.S. Mortality [PDF]

open access: yes, 2017
In this brief, author Shannon Monnat identifies trends in mortality rates from drugs, alcohol, and suicide by race and sex for adults aged 25 to 54, from the years 2000 to 2014. She reports that—nationwide--the mortality rate from deaths involving drugs,
Monnat, Shannon M.
core   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

Challenges of sharing individual participant data for secondary research on neglected tropical diseases: the experience of Drugs for Neglected Diseases initiative and a call for action

open access: yesBMJ Open
Introduction The Drugs for Neglected Diseases initiative (DNDi) is committed to maximising the scientific value of the individual participant data (IPD) it has collected during its 20 years of activity and the IPD it will collect in the future, while ...
Anastassia Negrouk   +5 more
doaj   +1 more source

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

open access: yesNew England Journal of Medicine, 2005
J. Lieberman   +12 more
semanticscholar   +1 more source

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

open access: yesMolecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung   +17 more
wiley   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon   +9 more
wiley   +1 more source

Salt production and iodization practices among artisanal salt producers in selected districts within the Greater Accra and Central Regions of Ghana

open access: yesHeliyon
Background: This study was conducted to assess salt production and iodization practices by artisanal salt producers located at six districts across Greater Accra and Central regions.
Benjamin Osei Tutu   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy